Daily Tech Briefing
AI 科技速览

每天 5 分钟内学习 AI。获取最新的人工智能新闻,理解其重要性,并学习如何将其应用于您的工作。

AI 快讯
CNBC AI · 2026/7/22 06:22:07
CNBC Daily Open: Generic problems, AI valuations and earnings on tap

CNBC Daily Open: Generic problems, AI valuations and earnings on tap

AI 中文解读
特朗普政府提议从2028年起对仿制药征收100%关税,同时中美计划在9月峰会前举行AI会谈,三星据称要砸200亿欧元投资法国AI初创MistralAI,而谷歌和特斯拉的财报今晚登场。这一连串消息看似分散,实则指向同一个趋势:全球科技、贸易和地缘政治正加速交织。 简单来说,仿制药就是品牌药专利过期后,其他公司生产的便宜版本,一旦加征高关税,美国消费者买药会更贵。AI会谈和可能的制裁则围绕“技术盗窃”展开,这会影响未来AI模型在不同国家的开发和共享方式。三星押注MistralAI,说明欧洲AI力量正在崛起,而科技巨头的财报将揭示AI到底能否真正转化为利润。 对普通人而言,仿制药关税可能直接推高药品开销;AI监管谈判会影响你用的智能助手或翻译工具是否好用、是否受限;科技股财报则可能引发股市波动,影响你的基金和养老金。总之,这周的消息提醒我们:大国博弈、AI竞赛和钱袋子之间的联系越来越紧密了。
Skip NavigationMarketsPre-MarketsU.S. MarketsEurope MarketsChina MarketsAsia MarketsWorld MarketsCurrenciesPrediction MarketsCryptocurrencyFutures & CommoditiesBondsFunds & ETFsBusinessEconomyFinanceHealth & ScienceMediaReal EstateEnergyClimateTransportationInvestigationsIndustrialsRetailWealthSportsLifeSmall BusinessInvestingPersonal FinanceFintechFinancial AdvisorsOptions ActionETF StreetBuffett ArchiveEarningsTrader TalkTechCybersecurityAIEnterpriseInternetMediaMobileSocial MediaCNBC Disruptor 50Tech GuidePoliticsWhite HousePolicyDefenseCongressExpanding OpportunityEurope PoliticsChina PoliticsAsia PoliticsWorld PoliticsVideoLatest VideoFull EpisodesLivestreamTop VideoLive AudioEurope TVAsia TVCNBC PodcastsCEO InterviewsDigital OriginalsWatchlistInvesting ClubTrust PortfolioAnalysisTrade AlertsMeeting VideosHomestretchJim's ColumnsEducationSubscribePROPro NewsJosh BrownMike SantoliCalls of the DayMy PortfolioLivestreamFull EpisodesStock ScreenerMarket ForecastOptions InvestingChart InvestingSubscribeLivestreamMenuMake ItselectUSAINTLLivestreamSearch quotes, news & videosLivestreamWatchlistSIGN INCreate free accountMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenu (function() { const userMembershipOnLastVisit = localStorage.getItem("cnbcMeta__cachedUserMembership"); if (!userMembershipOnLastVisit) { // If no user membership is stored, user is likely not logged in. // These users will typically see the banner. return; } const { isPro, isInvestingClubUser } = JSON.parse(userMembershipOnLastVisit); if (!(isPro || isInvestingClubUser)) { // We’re rendering the top banner for users who are not pro or investing club members. return; } // Hide the banner for pro and investing club users. const style = document.createElement("style"); style.id = "top-banner-placeholder-style"; style.innerHTML = "[data-top-banner-placeholder] { display: none; }"; document.head.appendChild(style); })() Daily OpenCNBC Daily Open: Generic problems, AI valuations and earnings on tapPublished Wed, Jul 22 20262:22 AM EDTLeonie KiddWATCH LIVEKey PointsPresident Donald Trump proposes 100% tariffs on generic pharmaceuticals from 2028. U.S. and China are expected to hold AI talks ahead of Trump's meeting with China's Xi Jinping in September. Treasury Secretary Scott Bessent says the U.S. could sanction China over AI model "theft."Samsung reportedly eyes another investment in MistralAI, valuing the French group at 20 billion euros ($22.82 billion).Secretary of State Marco Rubio says Iran is not serious about peace talks. Earnings today: Alphabet and Tesla report after the bell.In this articleAIR-FRBASSNLFFollow your favorite stocksCREATE FREE ACCOUNTAn employee monitors bottles as they move along the drug production line inside the packaging unit at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India,Bloomberg | Bloomberg | Getty ImagesHello, this is Leonie Kidd coming to you from London. A busy day for investors with a fresh tariff threat from the White House, more moving and shaking in the AI space, tension in Iran and another massive set of earnings on Wall Street. Read on!What you need to know todayPresident Donald Trump says the United States will raise tariffs on generic drugs to 100% in 2028, and 200% thereafter. Taking to Truth Social, he explained: "This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them." The stakes are high for India, as the country's pharmaceutical companies supply nearly 50% of all generic medicines consumed in America. All about AIThe U.S. and China are reportedly set to hold AI talks in September, ahead of Chinese
分享
阅读原文